scholarly journals P33 Rituximab as rescue therapy in advanced progressive systemic sclerosis associated interstitial lung disease

Thorax ◽  
2015 ◽  
Vol 70 (Suppl 3) ◽  
pp. A92.2-A92
Author(s):  
M Kokosi ◽  
P Saunders ◽  
K Karagiannis ◽  
F Chua ◽  
TM Maher ◽  
...  
Radiology ◽  
1990 ◽  
Vol 176 (3) ◽  
pp. 755-759 ◽  
Author(s):  
H Schurawitzki ◽  
R Stiglbauer ◽  
W Graninger ◽  
C Herold ◽  
D Pölzleitner ◽  
...  

2021 ◽  
pp. jrheum.201625
Author(s):  
Gonçalo Boleto ◽  
Jérôme Avouac ◽  
Yannick Allanore

Despite recent advances in the management of systemic sclerosis–associated interstitial lung disease (SSc-ILD), it remains the most common cause of death and a significant contributor to morbidity.1,2 SSc-ILD is characterized by a wide spectrum of disease courses, with some patients having limited nonprogressive fibrosis, whereas others develop rapid and extensive fibrosis leading to respiratory failure.3


CHEST Journal ◽  
1985 ◽  
Vol 88 (4) ◽  
pp. 263S-265 ◽  
Author(s):  
J. Ohar ◽  
C. Polatty ◽  
A. Robichaud ◽  
A. Fowler ◽  
G. Vetrovec ◽  
...  

2015 ◽  
Vol 51 (9) ◽  
pp. 440-448 ◽  
Author(s):  
Laura Gonzalez-Lopez ◽  
Alberto D. Rocha-Muñoz ◽  
Eva M. Olivas-Flores ◽  
Araceli Garcia-Gonzalez ◽  
Ana R. Peguero-Gómez ◽  
...  

1985 ◽  
Vol 131 (4) ◽  
pp. 612-617 ◽  
Author(s):  
Giovanni A. Rossi ◽  
Peter B. Bitterman ◽  
Stephen I. Rennard ◽  
Victor J. Ferrans ◽  
Ronald G. Crystal

Sign in / Sign up

Export Citation Format

Share Document